Methyclothiazide Pregnancy and Breastfeeding Warnings
Brand names: Aquatensen, Enduron
Methyclothiazide Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: B
Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Methyclothiazide Breastfeeding Warnings
A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
Excreted into human milk: Yes
Comments: According to some authorities, this drug may be used during breastfeeding if required by the mother. High doses, however, may decrease breastmilk production.
See also
References for pregnancy information
- (2001) "Product Information. Enduron (methyclothiazide)." Abbott Pharmaceutical
References for breastfeeding information
- (2001) "Product Information. Enduron (methyclothiazide)." Abbott Pharmaceutical
- United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.